相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naive patients
Guillaume Ploussard et al.
BJU INTERNATIONAL (2011)
Long-Term Survival After Radical Prostatectomy Versus External-Beam Radiotherapy for Patients With High-Risk Prostate Cancer
Stephen A. Boorjian et al.
CANCER (2011)
A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988-2006
Firas Abdollah et al.
EUROPEAN UROLOGY (2011)
Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
Tanya B. Dorff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients
Paul R. Womble et al.
JOURNAL OF UROLOGY (2011)
Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification
Guillaume Ploussard et al.
UROLOGY (2011)
Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer
Guillaume Ploussard et al.
BJU INTERNATIONAL (2010)
Comparative Risk-Adjusted Mortality Outcomes After Primary Surgery, Radiotherapy, or Androgen-Deprivation Therapy for Localized Prostate Cancer
Matthew R. Cooperberg et al.
CANCER (2010)
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
Martin Spahn et al.
EUROPEAN UROLOGY (2010)
Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix
Michael J. Zelefsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
G. Ploussard et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?
Stacy Loeb et al.
UROLOGY (2010)
Phase II Trial of Neoadjuvant Docetaxel and Gefitinib Followed by Radical Prostatectomy in Patients With High-Risk, Locally Advanced Prostate Cancer
Jacqueline Vulky et al.
CANCER (2009)
A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma
M. D. Shelley et al.
CANCER TREATMENT REVIEWS (2009)
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free Survival
Carvell T. Nguyen et al.
JOURNAL OF UROLOGY (2009)
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
D. R. Shepard et al.
JOURNAL OF UROLOGY (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Anders Widmark et al.
LANCET (2009)
Duration of Androgen Suppression in the Treatment of Prostate Cancer
Michel Bolla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy
Stacy Loeb et al.
EUROPEAN UROLOGY (2008)
Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer
Michael J. Zelefsky et al.
EUROPEAN UROLOGY (2008)
EAU guidelines on prostate cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2008)
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
Bruce J. Trock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
Eric M. Horwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer
Kim N. Chi et al.
JOURNAL OF UROLOGY (2008)
Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: A systematic review and meta-analysis
Scott C. Morgan et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer
Jeremy P. Cetnar et al.
UROLOGY (2008)
Veterans affairs cooperative studies program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer
Bruce Montgomery et al.
UROLOGY (2008)
Radical prostatectomy for clinically localized, high risk prostate cancer: Critical analysis of risk assessment methods
Ofer Yossepowitch et al.
JOURNAL OF UROLOGY (2007)
Intermediate-term potency continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer
Stacy Loeb et al.
UROLOGY (2007)
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: A multi-institutional pilot study
Adam S. Kibel et al.
JOURNAL OF UROLOGY (2007)
Radical prostatectomy for clinical stage T3a disease
Stephen J. Freedland et al.
CANCER (2007)
Adjuvant radiotherapy for pathologically advanced prostate cancer - A randomized clinical trial
Ian M. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10
Patrick J. Bastian et al.
CANCER (2006)
Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading
John F. Donohue et al.
JOURNAL OF UROLOGY (2006)
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer
Brett S. Carver et al.
JOURNAL OF UROLOGY (2006)
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
Edward M. Messing et al.
LANCET ONCOLOGY (2006)
Radical prostatectomy for locally advanced prostate cancer: Results of a feasibility study (EORTC 30001)
H Van Poppel et al.
EUROPEAN JOURNAL OF CANCER (2006)
Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organisation for research and treatment of cancer (EORTC) trial 30891
UE Studer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
DG McLeod et al.
BJU INTERNATIONAL (2006)
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
AJ Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Postoperative radiotherapy after radical prostatectomy:: a randomised controlled trial (EORTC trial 22911)
M Bolla et al.
LANCET (2005)
Treatment of patients with high risk localized prostate cancer: Results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE)
MV Meng et al.
JOURNAL OF UROLOGY (2005)
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome
JF Ward et al.
BJU INTERNATIONAL (2005)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer
MP Wirth et al.
EUROPEAN UROLOGY (2004)
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
KA Roehl et al.
JOURNAL OF UROLOGY (2004)
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
AV D'Amico et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy
LH Klotz et al.
JOURNAL OF UROLOGY (2003)
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863
A Zurlo et al.
EUROPEAN UROLOGY (2002)
Salvage radiotherapy for rising or persistent PSA after radical prostatectomy
DY Song et al.
UROLOGY (2002)
Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer
H Zincke et al.
JOURNAL OF UROLOGY (2001)
Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer
PE Clark et al.
UROLOGY (2001)
分享论文
